Product
SAIL66
1 clinical trial
1 indication
Indication
Solid TumorClinical trial
A Phase I Open-label, Multicenter Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2028-12-31